Many OB-GYNs breathed a sigh of relief Thursday after the U.S. Supreme Court ruled that telehealth access to the abortion drug mifepristone can continue until after the U.S. 5th Circuit Court of Appeals has issued a ruling in the federal lawsuit Louisiana v.